title: Stability of hemoglobin and albumin adducts of benzene oxide and 1,4-benzoquinone after administration of benzene to F344 rats.
abstract: The stability of cysteinyl adducts of benzene oxide (BO) and mono-S-substituted cysteinyl adducts of 1,4-benzoquinone (1,4-BQ) was investigated in both hemoglobin (Hb) and albumin (Alb) following administration of a single oral dose of 400 mg [U-14C/13C6]benzene/kg body weight to F344 rats. Total radiobound adducts to Hb were stable, as were adducts formed by the reaction of [13C6]BO with cysteinyl residues on Hb. In both cases adduct stability was indicated by zero-order kinetics with decay rates consistent with the lifetime of rat erythrocytes. Hb adducts of 1,4-BQ were not detected, possibly due to the production of multi-S-substituted adducts within the erythrocyte. Regarding Alb binding, total radiobound adducts decayed more rapidly than expected (half-life of 0.4 days), suggesting that uncharacterized benzene metabolites were noncovalently bound or formed unstable adducts with Alb. Although adducts from reactions of BO and 1,4-BQ with Alb both decayed with rates consistent with those of Alb turnover in the rat, the half-life for 1,4-BQ-Alb (2.5 days) was shorter than that for BO-Alb (3.1 days), suggesting some instability of 1,4-BQ-Alb. Assuming similar rates of adduct instability in humans and rats, the 1,4-BQ-Alb adducts would be eliminated with a half-life of approximately 8 days, compared with BO-Alb, which would be expected to turnover with Alb (half-life of approximately 21 days).
authors.affiliation: Department of Environmental Sciences and Engineering, School of Public Health, University of North Carolina at Chapel Hill, 27599-7400, USA.
authors.forename: M A
authors.initials: MA
authors.lastname: Troester
authors.forename: A B
authors.initials: AB
authors.lastname: Lindstrom
authors.forename: L L
authors.initials: LL
authors.lastname: Kupper
authors.forename: S
authors.initials: S
authors.lastname: Waidyanatha
authors.forename: S M
authors.initials: SM
authors.lastname: Rappaport
mesh_terms: D000418:Albumins / Q000378:metabolism*; D000818:Animals; D001554:Benzene / Q000493:pharmacokinetics*; D016227:Benzoquinones / Q000378:metabolism*; D001711:Biotransformation; D002273:Carcinogens / Q000493:pharmacokinetics*; D003510:Cyclohexanes / Q000378:metabolism*; D008401:Gas Chromatography-Mass Spectrometry; D006207:Half-Life; D006454:Hemoglobins / Q000378:metabolism*; D008297:Male; D011485:Protein Binding; D051381:Rats; D011916:Rats, Inbred F344
chemical_list: D000418:Albumins; D016227:Benzoquinones; D002273:Carcinogens; D003510:Cyclohexanes; D006454:Hemoglobins; C004532:quinone; D001554:Benzene; C023372:benzene oxide